Tyrosine kinase를 경유한 ERK1/2의 활성화로 인한 TRAIL에 의해 유발된 HeLa 세포자멸사시 세포보호작용
The activation of ERK1/2 via tryosine kinase pathway attenuates TRAIL-induced apoptosis in HeLa cell
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)는 암세포에서 세포자멸사를 유발시키는 세포외 신호전달을 가져오는 물질이다. TRAIL에 의한 세포자멸사 신호전달 체계를 규명하기 위하여 우리는 HeLa 세포를 사용해서 세포자멸사에서 ERK1/2의 역할을 알아보았다. 이 연구에서 우리는 TRAIL이 tyrosine kinase를 통해서 ERK1/2가 활성화 된다는 것을 밝혔다. 이것이 세포자멸사를 막아주는 Bcl-2 단백질의 양을 늘린다. Tyrosine kianse의 억제제인 genistein은 매우 극적으로 ERK1/2의 활성화정도를 막으며 또한 세포사멸도 증가시킨다. 더욱이 PD98059를 이용한 ERK1/2의 활성화를 억제한 결과 ERK1/2의 활성화와 Bcl-2 단백질의 양이 줄어듦을 통해서 세포자멸사가 증가되었다. 결과적으로 우리의 연구는 tryrosine kinase를 경유한 ERK1/2의 활성화가 TRAIL에 의한 세포자멸사 과정중에 Bcl-2의 양을 증가시킴으로서 세포내 방어 시스템의 세포보호 작용을 하게 된다는 것을 보여준 것이라 하겠다.
Abstract
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) serves as an extracellular signal triggering apoptosis in tumor cells. To characterize the molecular events involved in TRAIL-induced apoptotic signaling, we investigated the role of extracellular signal-regulated kinase 1/2 (ERK1/2) in the apoptosis using HeLa cells. Here we show that TRAIL pronounced ERK1/2 activation through a tyrosine kinase-dependent mechanism, subsequently elevated anti-apoptotic Bcl-2 protein levels. Pretreatment with Genistein, an inhibitor of tyrosine kinase, significantly attenuated ERK1/2 activation and enhanced cell death. Moreover, inhibition of ERK1/2 with PD98059 promoted apoptotic cell death through the down-regulation of ERK1/2 activity and Bcl-2 protein levels. Taken together, our results suggest that the activation of ERK1/2 via tyrosine kinase pathway plays a protective role as the mechanism of cellular defense through the up-regulation of Bcl-2 protein levels in TRAIL-induced apoptosis.
참고문헌 (37)
- "The activation of p38and apoptosis by the inhibition of Erk is antagonized bythe phosphoinositide 3-kinase", Akt pathway, 1998, pp.273, 10792~10797
- "MEK", ERK signaling pathway regulates theexpression of Bcl-2 and Mcl-1 and promotessurvival of human pancreatic cancer cells, 2000, 355~369
- "Mammalian MAP kinase signallingcascades", 410, pp.37~40 (2001)
- "Endogenous and exogenousfibroblast growth factor 2 support survival of chick retinalneurons by control of neuronal neuronal bcl-x and bcl-2 expression through a fibroblast berowth factor receptor1- and ERK-dependent pathway", pp.151~163 (2000)
- "Systemicoverexpression of BCL-2 in the hematopoietic systemprotects transgenic mice from the consequences of lethalirradiation", 91, pp.2272~228 (1998)
- "Osteoprotegerin is a receptor for the cyto-toxic ligandTRAIL", pp.14363~14367 (1998)
- "Fibroblast growth factor-2suppression of tumor necrosis factor alpha-mediatedapoptosis requires Ras and the activation of mitogenactivatedprotein kinase", 271, pp.14560~14566 (1996)
- "Bcl-2 promotes survival in hematopoietic cellsinduced to apoptose by growth factor withdrawal by stabilizing a form of metabolic arrest", pp.4680~4688 (1997)
- "Mitogen-activated protein kinasemediatedFas apoptotic signaling pathway", 94, pp.3302~3307 (1997)
- "Stimulation of ultraviolet-induced apoptosis ofhuman fibroblast UVr-1 cells by tyrosine kinase inhibitors", 444, pp.173~176 (1999)
- "Role of extracellularsignal-regulated protein kinases in apoptosis byasbestos and H2O2", 273, pp.~1035 (1997)
- "Tumor necrosis factor-alpha induces theexpression of DR6 a member of the TNF receptor family through activation of NF-kappaB", pp.7965~7965 (2001)
- "Failure of Bcl-2 to block cytochrome c redistributionduring TRAIL-induced apoptosis", 471, pp.93~98 (2000)
- "Hwansodan protects PC12 cells", pp.227~235 (2000)
- "kinase in TRAIL", Apo2L-induced apoptosis, 2002, 313~318
- "Sodium nitroprusside enhancesTRAIL-induced apoptosis via a mitochondria-dependentpathway in human colorectal carcinoma CX-1 cells", 20, pp.1476~1485 (2001)
- "Gprotein-coupled receptors mediate two functionally distinctpathways of tyrosine phosphorylation in rat 1a fibroblasts Shc phosphorylation and receptor endocytosis correlatewith activation of Erk kinases", pp.31648~31656 (1997)
- "Activation of RSK by UV-light phosphorylation dynamics and involvement of the MAPKpathway", pp.4221~19 4229 (2000)
- "TRAIL", Apo2L activates, 1998, 33091~33098
- "Requirement of activation of JNKand p38 for environmental stress-induced erythroiddifferentiation and apoptosis and of inhibition of ERK forapoptosis", 94, pp.853~863 (1999)
- "regulateapoptosis and bcl-2 expression in a growth factor-dependentcell line", pp.22733~22736 (1993)
- "The receptor for the cytotoxic ligand TRAIL", 276, pp.111~113 (1997)
- "Anantagonist decoy receptor and a death domain-containingreceptor for TRAIL", 277, pp.815~818 (1997)
- "enhances apoptosis and cell cyclearrest in K562 cells treated with gamma-irradiation", pp.107~113 (2000)
- "Bcl-2 blocks cisplatin-induced apoptosis by suppression ofERK-mediated p53 accumulation in B104 cells", 93, pp.18~26 (2001)
- "Induction of apoptosis by Apo-2 ligand anew member of the tumor necrosis factor cytokine family", pp.12687~12690 (1996)
- "specific messages from ubiquitous messengers", pp.2435~244
- "ERKs and p38 kinasephosphorylate p53 protein at serine 15 in response to UVradiation", 275, pp.20444~20449 (2000)
- "Mechanisms and ClinicalApplications in Cancer", pp.535~546 (2001)
- "inhibition of apoptosis byblocking nuclear factor of activated T lymphocytes", pp.253~265 (1999)
- "Overexpression of BCL2 blocks TNF-relatedapoptosis-inducing ligand", 280, pp.788~797 (2001)
- "and CREB bindingprotein and p300 is recruited to the tumor necrosis factoralpha promoter in vivo", pp.6084~6094 (2000)
- "High intensity ERKsignal mediates hepatocyte growth factor-induced proliferationinhibition of the human hepatocellular carcinomacell line HepG2", 276, pp.40968~40976 (2001)
- "Tumoricidal activity of tumor necrosis factor-relatedapoptosis-inducing ligand in vivo", pp.157~163 (1999)
- "Identification and characterization of a newmember of the TNF family that induces apoptosis", pp.673~682 (1995)
- "MEK1 activationrescues Jurkat T cells from Fas-induced apoptosis", pp.67~77 (1999)
- "Opposing effects of ERK and JNK-p38 MAP kinases onapoptosis", 270, pp.1326~1331 (1995)
